Skip to content

A multicenter case-control study for early detection of psoriatic arthritis using ultrasonography and easy-to-use questionnaires in psoriasis patients in the outpatient dermatology clinic

A multicenter case-control study for early detection of psoriatic arthritis using ultrasonography and easy-to-use questionnaires in psoriasis patients in the outpatient dermatology clinic - JOINT skin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46760
Enrollment
150
Registered
2018-04-19
Start date
2018-05-23
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronich skin inflammation with joint inflammation Psoriasis psoriatic arthritis

Interventions

None listed

Sponsors

Maasstadziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Patients that are diagnosed with psoriasis by their dermatologist * be able to read/write the Dutch language * provide a written informed consent * age > 18 years

Exclusion criteria

Exclusion criteria: - Patients who already have the diagnosis of PsA according to a rheumatologist - Patients using conventional disease-modifying antirheumatic drugs (DMARDs) or biological DMARDs such as TNF-, IL-17A or IL-23 inhibitors. * Patients using cyclosporin or tacrolimus. * Patients using systemic corticosteroids.

Design outcomes

Primary

MeasureTime frame
The sensitivity and specificity of the PEST-questionnaire and ultrasonography in identifying PsO patients having PsA according to a rheumatologist and meet the CASPAR-criteria.

Secondary

MeasureTime frame
Quality of life and physical functioning after 1 year after screening

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)